| Understand Colon Cancer with MyBiopsy.Org; Schedule a Screening
Currently, the site includes information on colon cancer, or colon adenocarcinoma, as well as precancerous colon polyps - colon adenomatous polyp. Each page on www.MyBiopsy.org was developed by pathologists - physicians who examine tissues and fluids to diagnose disease and to assist in making treatment decisions. The pages include answers to questions about colon cancer, lists of available treatment options, a glossary of key terms, and pictures of normal and diseased tissues, among other features. All of the information available on the College's Web site is featured in three formats: HTML, PDF, and Microsoft Word. In addition to information about colon cancer, the site also includes information on 36 other common cancer diseases and cancer-related conditions, including those affecting the lungs, breast, prostate, and skin, among others.
Friends plan benefit in Ixonia for Matt Krueger
Krueger, 19, of Watertown, was diagnosed with a rare cancer called mucinous adenocarcinoma in October 2008. The rare form of cancer sits on the surface of organs and produces mucous. In October doctors removed half of his colon and about 98 percent of the cancer. He was told the remaining portions of cancer had to be removed by a specialist. Since then he had three months of chemotherapy treatments.On Sunday, Krueger and his family will drive to Washington, D.C. where he will have a surgery done by a specialist to remove the remaining cancer. After surgery he will have another round of chemotherapy treatments.The benefit on Saturday will include a spaghetti dinner, from 5 to 9 p.m., and entertainment from the live band, the Screamin' Nighthawks, from 7 to 11 p.m.The event will include raffles, a silent auction and two live auctions with help from the Miller Lite Girls.
Edmond Firefighters With Cancer Battling For Benefits
Weaver had adenocarcinoma, a type of cancer that can develop in cells that line several internal organs. Cheryl Weaver said her husband told her it was a huge relief the day he learned that his workers' compensation benefits were approved. "I didn't know the impact until a couple months later," Cheryl Weaver said. "I just don't think it is right for these guys not to get their benefits." For Vernon, life has been rough. Eight surgeries, multiple rounds of chemotherapy treatments and the fight with his employer have been tough, and a financial burden on his family. "Everything I have been through has been a struggle," Vernon said. "The emotions, doubts and fears will be well worth it if a change is made." Written by The Daily Oklahoman .
Health and Fitness
Chase Cancer Center, is this year's guest distinguished lecturer. His topic is "Proper Staging, Resection and Processing of Pancreatic Adenocarcinoma." Open to the public. Reservations encouraged. Call 448-3234. Healthy Living Seminars on Heart Disease at YMCA: Various health-related topics led by HealthSpring professionals. Topic for March is "Heart Disease Awareness." Free, open to the community: Wednesday: 11:30 a.m. Millington Family YMCA, 7725 E. Navy Circle, Millington. Call 873-1434. March 25: 11:30 a.m. YMCA at Schilling Farms, 1185 Schilling Blvd. E., Collierville. 850-9622. March 26: 10:30 a.m. Thomas B. Davis Family YMCA, 4727 Elvis Presley Blvd. Call 398-2366. Surgical Weight-Loss Options: Noon Wednesday (seminar room 1); and 7 p.m. March 23 (seminar rooms 2 and 3) at Baptist Memorial Hospital-Memphis, 6019 Walnut Grove Road.
Medicine used for baldness may prevent Prostate Cancer
Abnormal and malignant growth of cells in prostate gland can lead to Prostate cancer (or Adenocarcinoma). It is the second most common cancer and found only in men. Higher levels of hormone (especially Androgens) can be of high risk and may induce growth of tumor cells. Other factors may include age, hereditary (or genetic), diet, obesity, smoking or infection and inflammation of prostate gland. Recent guidelines published by American Society of Clinical Oncology and the American Urological Association reveal that common drug, Finasteride, used in male baldness is effective in preventing Prostate cancer. Guidelines also recommend a daily dose of Finasteride for the male above age 55. It is believed that high doses of Finasteride acts by interfering male hormones which fuel the growth of cancerous cell.
Short-Course Radiation May Not Improve Recurrence and Survival in
Dr. Tayyab noted that in other studies, "short-course radiotherapy has been shown to improve relapse-free survival following surgery for rectal cancer." Nevertheless, in this particular study, the radiation therapy given to patients with rectal cancer appeared to have no effect on either recurrence or overall survival. Moreover, he pointed out, patients with low rectal cancers who were treated with neoadjuvant short-course radiation therapy tended to have more postsurgical complications.
[Presentation title: Analysis of Impact of Short Course Pre Operative Radiotherapy on Local Relapse and Survival Outcomes in Patients Following Abdominoperineal Excision for Rectal Adenocarcinoma. Abstract P137]
.
Neoadjuvant Chemoradiation May Permit Resection of Pancreatic
Society of Surgical Oncology (SSO) 62nd Annual Cancer Symposium.
Almost half of patients with borderline resectable pancreatic adenocarcinoma were able to undergo pancreatic resection following chemoradiation, reported lead author Jayme B. Stokes, MD, University of Virginia, Charlottesville, Virginia, speaking at a poster session here on March 7.
"This is a subset of patients who would not otherwise be able to undergo resection; however, we found that if you treat them preoperatively with radiation and chemotherapy, half of those patients could then go on to pancreatic resection with a survival benefit that comes along with resection of the cancer," said Dr. Stokes.
Patients with resectable pancreatic cancer may experience median survival in excess of 2 years after multidisciplinary therapy including surgery, the research team noted.
An apple a day could keep breast cancer at bay!
Over the past year, these researchers have conducted about six studies where rats were exposed to a type of adenocarcinoma, a leading cause of breast cancer. These studies were published by Rui Hai Liu, Cornell associate professor of food science and a member of Cornell's Institute for Comparative and Environmental Toxicology. These hairy animals were fed the human equivalent of one apple per day for a period of about 6 months. Liu along with his team discovered that apples significantly reduced the size of tumors in these rats. In fact, it was discovered that the more extracts they were fed; the more their breast tumors were reduced. Professor Liu says that, “We not only observed that the treated animals had fewer tumors, but the tumors were smaller, less malignant and grew more slowly compared with the tumors in the untreated rats." It was noticed that in the rats that were fed one apple a day, only about 57 percent of them developed cancer.
Trial of a lifetime
Patients eligible for the study include men or women 18 or older with untreated stage IV metastatic adenocarcinoma of the pancreas. Patients must also have acceptable bone marrow, liver functions and kidney functions. "The drugs are given intravenously in combination and are given on different days of the week such as day one, day eight, day 15 of a 28-day cycle," Gowland said. "Appropriate diagnostic imaging studies are then performed to evaluate the response to the drugs." About pancreatic cancer The American Cancer Society estimates nearly 38,000 people will be diagnosed with pancreatic cancer this year, with almost 34,000 dying from the disease, making it the fourth leading cause of cancer death overall in the United States. Pancreatic cancer is sometimes called a "silent disease" because early pancreatic cancer often does not cause symptoms.
NCCN Announces Updates to Pancreatic Adenocarcinoma Guidelines
Pancreatic adenocarcinoma is the second most common cause of death from gastrointestinal cancer. HOLLYWOOD, Fla., March 13 /PRNewswire-USNewswire/ -- The National Comprehensive Cancer Network (NCCN) presented important updates to the NCCN Clinical Practice Guidelines in Oncology(TM) for Pancreatic Adenocarcinoma today at the NCCN 14th Annual Conference. Margaret A. Tempero, MD, of UCSF Helen Diller Family Comprehensive Cancer Center, presented the updated NCCN Guidelines that promoted more individualized management, clarified required diagnostic imaging, and placed increased emphasis on systemic therapy in all disease stages. The 2009 version of the NCCN Guidelines clarify the recommendations for diagnostic imaging in patients with pancreatic cancer.
|
